z-logo
open-access-imgOpen Access
Searching for anti-glioma activity. Ribonucleoside analogues with modifications in nucleobase and sugar moieties.
Author(s) -
Grzegorz Framski,
Dariusz Wawrzyniak,
Zofia JahnzWechmann,
Agnieszka Szymańska-Michalak,
Adam Kraszewski,
Jan Barciszewski,
Jerzy Boryski,
Jacek Stawiński
Publication year - 2016
Publication title -
acta biochimica polonica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.452
H-Index - 78
eISSN - 1734-154X
pISSN - 0001-527X
DOI - 10.18388/abp.2016_1338
Subject(s) - ribonucleoside , nucleobase , guanine , hela , glioma , chemistry , cell culture , moiety , biochemistry , stereochemistry , cell , dna , cancer research , biology , rna , gene , nucleotide , genetics
Several ribonucleoside analogues with modifications in the nucleobase and sugar moiety have been screened for anti-glioma activity in the T98G glioma cell line using cervical (HeLa) cell line as reference human malignant cells, and lung fibroblast (MCR-5) cell line as non-cancerous reference cells. Among the investigated compounds, ribonucleosides containing 6-chloropurine (3), 7-guanine (5) and a pyrrolopyrimidine (18) as nucleobases, show promising anti-glioma activity with good selectivity indices, and can be considered as lead structures for further anti-cancer studies.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom